Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Ordás

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Magnetic Resonance Imaging Clinics of North America|November 19, 2013
MR colonography in inflammatory bowel diseaseJordi Rimola, Ingrid Ordás
Alimentary Pharmacology & Therapeutics|December 17, 2020
Letter: accuracy of magnetic resonance index of activity score to predict response to biologics in Crohn's disease-authors' replyJordi Rimola, Julian Panés, Ingrid Ordás
Gut|November 10, 2011
Anti-TNF antibody therapy in Crohn's disease: the risk of a switchElena Ricart, Ingrid Ordás, Julián Panés
Gastroenterologia Y Hepatologia|November 11, 2009
[Smoking and Crohn's disease: cessation strategies]María J Etchevers, Ingrid Ordás Jiménez
Expert Review of Clinical Immunology|July 3, 2010
Stem cell treatment for Crohn's diseaseJulián Panés, Ingrid Ordás, Elena Ricart
Scandinavian Journal of Gastroenterology|December 20, 2014
Magnetic resonance enterography in Crohn's disease: optimal use in clinical practice and clinical trialsJordi Rimola, Julián Panés, Ingrid Ordás
Drugs|January 30, 2010
Optimizing the use of tumour necrosis factor inhibitors in Crohn's disease: a practical approachMaria Josefina Etchevers, Ingrid Ordás, Elena Ricart
Abdominal Imaging|June 19, 2009
Colonic Crohn's disease: value of magnetic resonance colonography for detection and quantification of disease activityJordi Rimola, Ingrid Ordás, Sonia Rodríguez, et al.
Gut|October 15, 2011
Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a changeIngrid Ordás, Brian G Feagan, William J Sandborn
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2012
Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel diseaseIngrid Ordás, Brian G Feagan, William J Sandborn
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Magnetic Resonance Imaging Clinics of North America|November 19, 2013
MR colonography in inflammatory bowel diseaseJordi Rimola, Ingrid Ordás
Alimentary Pharmacology & Therapeutics|December 17, 2020
Letter: accuracy of magnetic resonance index of activity score to predict response to biologics in Crohn's disease-authors' replyJordi Rimola, Julian Panés, Ingrid Ordás
Gut|November 10, 2011
Anti-TNF antibody therapy in Crohn's disease: the risk of a switchElena Ricart, Ingrid Ordás, Julián Panés
Gastroenterologia Y Hepatologia|November 11, 2009
[Smoking and Crohn's disease: cessation strategies]María J Etchevers, Ingrid Ordás Jiménez
Expert Review of Clinical Immunology|July 3, 2010
Stem cell treatment for Crohn's diseaseJulián Panés, Ingrid Ordás, Elena Ricart
Scandinavian Journal of Gastroenterology|December 20, 2014
Magnetic resonance enterography in Crohn's disease: optimal use in clinical practice and clinical trialsJordi Rimola, Julián Panés, Ingrid Ordás
Drugs|January 30, 2010
Optimizing the use of tumour necrosis factor inhibitors in Crohn's disease: a practical approachMaria Josefina Etchevers, Ingrid Ordás, Elena Ricart
Abdominal Imaging|June 19, 2009
Colonic Crohn's disease: value of magnetic resonance colonography for detection and quantification of disease activityJordi Rimola, Ingrid Ordás, Sonia Rodríguez, et al.
Gut|October 15, 2011
Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a changeIngrid Ordás, Brian G Feagan, William J Sandborn
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2012
Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel diseaseIngrid Ordás, Brian G Feagan, William J Sandborn
Pageof 8